{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:47:18Z","timestamp":1784270838395,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/bmt.2016.194","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T13:43:25Z","timestamp":1473687805000},"page":"20-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes"],"prefix":"10.1038","volume":"52","author":[{"given":"J E","family":"Brammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gaballa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R T","family":"Maziarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kebriaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"BFbmt2016194_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10552-008-9147-4","volume":"19","author":"X Han","year":"2008","unstructured":"Han X, Kilfoy B, Zheng T, Holford TR, Zhu C, Zhu Y et al. Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control 2008; 19: 841\u2013858.","journal-title":"Cancer Causes Control"},{"key":"BFbmt2016194_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18: 547\u2013561.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016194_CR3","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1002\/cncr.28930","volume":"120","author":"ME Rytting","year":"2014","unstructured":"Rytting ME, Thomas DA, O'Brien SM, Ravandi-Kashani F, Jabbour EJ, Franklin AR et al. Augmented Berlin-Frankfurt-Munster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL). Cancer 2014; 120: 3660\u20133668.","journal-title":"Cancer"},{"key":"BFbmt2016194_CR4","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1080\/10428190802517732","volume":"49","author":"JE Chang","year":"2008","unstructured":"Chang JE, Medlin SC, Kahl BS, Longo WL, Williams EC, Lionberger J et al. Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. Leuk Lymphoma 2008; 49: 2298\u20132307.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016194_CR5","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","volume":"106","author":"JM Rowe","year":"2005","unstructured":"Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993. Blood 2005; 106: 3760\u20133767.","journal-title":"Blood"},{"key":"BFbmt2016194_CR6","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","volume":"114","author":"DI Marks","year":"2009","unstructured":"Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, DeWald G et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993). Blood 2009; 114: 5136\u20135145.","journal-title":"Blood"},{"key":"BFbmt2016194_CR7","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.bbmt.2012.07.011","volume":"18","author":"M Bakr","year":"2012","unstructured":"Bakr M, Rasheed W, Mohamed SY, Al-Mohareb F, Chaudhri N, Al-Sharif F et al. Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2012; 18: 1897\u20131904.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016194_CR8","doi-asserted-by":"crossref","unstructured":"Cahu XLM, Giebel S, Socie G et al Myeloablative allogeneic hematopoietic stem cell transplantation for adult patients with T-cell acute lymphoblastic leukemia: a survey from the acute leukemia working party of the european group for blood and marrow transplantation (EBMT). Blood 2012: Abstract 356.","DOI":"10.1182\/blood.V120.21.356.356"},{"key":"BFbmt2016194_CR9","doi-asserted-by":"crossref","unstructured":"Hoelzer DTE, Arnold R, Joachim Beck, Beelen D et al Successful subtype oriented treatment strategies in adult T-ALL; results of 744 patients treated in three consecutive GMALL studies. Blood 2009: Abstract 324.","DOI":"10.1182\/blood.V114.22.324.324"},{"key":"BFbmt2016194_CR10","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1182\/blood-2014-09-599894","volume":"125","author":"N Dhedin","year":"2015","unstructured":"Dhedin N, Huynh A, Maury S, Tabrizi R, Beldjord K, Asnafi V et al. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood 2015; 125: 2486\u20132496.","journal-title":"Blood"},{"key":"BFbmt2016194_CR11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"M Bruggemann","year":"2006","unstructured":"Bruggemann M, Raff T, Flohr T, Gokbuget N, Nakao M, Droese J et al. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 2006; 107: 1116\u20131123.","journal-title":"Blood"},{"key":"BFbmt2016194_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1182\/blood-2006-07-037093","volume":"109","author":"T Raff","year":"2007","unstructured":"Raff T, Gokbuget N, Luschen S, Reutzel R, Ritgen M, Irmer S et al. Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06\/99 and 07\/03 trials. Blood 2007; 109: 910\u2013915.","journal-title":"Blood"},{"key":"BFbmt2016194_CR13","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","volume":"120","author":"N Gokbuget","year":"2012","unstructured":"Gokbuget N, Kneba M, Raff T, Trautmann H, Bartram CR, Arnold R et al. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood 2012; 120: 1868\u20131876.","journal-title":"Blood"},{"key":"BFbmt2016194_CR14","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","volume":"99","author":"MJ Willemse","year":"2002","unstructured":"Willemse MJ, Seriu T, Hettinger K, d'Aniello E, Hop WC, Panzer-Grumayer ER et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 2002; 99: 4386\u20134393.","journal-title":"Blood"},{"key":"BFbmt2016194_CR15","doi-asserted-by":"crossref","unstructured":"Wood BL WSS, Dunsmore KP, Devidas M et al. T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in children's oncology group (COG) study AALL0434. Blood 2014; 124 Abstract 1.","DOI":"10.1182\/blood.V124.21.1.1"},{"key":"BFbmt2016194_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.clml.2014.01.002","volume":"14","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Slack R, Jorgensen JL, Wang SA, Rondon G, de Lima M et al. The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Clin Lymphoma Myeloma Leuk 2014; 14: 319\u2013326.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFbmt2016194_CR17","first-page":"421723","volume":"2014","author":"M Bar","year":"2014","unstructured":"Bar M, Wood BL, Radich JP, Doney KC, Woolfrey AE, Delaney C et al. Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia. Leuk Res Treat 2014; 2014: 421723.","journal-title":"Leuk Res Treat"},{"key":"BFbmt2016194_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147\u2013156.","journal-title":"Lancet Oncol"},{"key":"BFbmt2016194_CR19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.leukres.2013.06.010","volume":"37","author":"A Allen","year":"2013","unstructured":"Allen A, Sireci A, Colovai A, Pinkney K, Sulis M, Bhagat G et al. Early T-cell precursor leukemia\/lymphoma in adults and children. Leuk Res 2013; 37: 1027\u20131034.","journal-title":"Leuk Res"},{"key":"BFbmt2016194_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/bjh.12882","volume":"166","author":"K Patrick","year":"2014","unstructured":"Patrick K, Wade R, Goulden N, Mitchell C, Moorman AV, Rowntree C et al. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol 2014; 166: 421\u2013424.","journal-title":"Br J Haematol"},{"key":"BFbmt2016194_CR21","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","volume":"127","author":"N Jain","year":"2016","unstructured":"Jain N, Lamb AE, O'Brien S, Ravandi F, Konopleva M, Jabbour E et al. Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype. Blood 2016; 127: 1863\u20131869.","journal-title":"Blood"},{"key":"BFbmt2016194_CR22","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1182\/blood-2011-01-329441","volume":"118","author":"N Gokbuget","year":"2011","unstructured":"Gokbuget N, Basara N, Baurmann H, Beck J, Bruggemann M, Diedrich H et al. High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia\/lymphoma offers curative option with subsequent stem cell transplantation. Blood 2011; 118: 3504\u20133511.","journal-title":"Blood"},{"key":"BFbmt2016194_CR23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","volume":"109","author":"AK Fielding","year":"2007","unstructured":"Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study. Blood 2007; 109: 944\u2013950.","journal-title":"Blood"},{"key":"BFbmt2016194_CR24","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumors","author":"MJ Borowitz","year":"2008","unstructured":"Borowitz MJ CJ. T-Lymphoblastic Leukaemia\/Lymphoma. In: Swerdlow SH, Campo E, Harris NL et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumors. International Agency for Research on Cancer (IARC): Lyon, France, 2008."},{"key":"BFbmt2016194_CR25","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783\u20131786.","journal-title":"Leukemia"},{"key":"BFbmt2016194_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt2016194_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BFbmt2016194_CR28","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","volume":"111","author":"V Pullarkat","year":"2008","unstructured":"Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR . Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood 2008; 111: 2563\u20132572.","journal-title":"Blood"},{"key":"BFbmt2016194_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10428194.2016.1160080","volume":"57","author":"RD Cassaday","year":"2016","unstructured":"Cassaday RD, Alan Potts D Jr, Stevenson PA, Bar M, Georges GE, Shustov AR et al. Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia. Leuk Lymphoma 2016; 57: 1\u201310.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016194_CR30","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1182\/blood-2010-02-266551","volume":"116","author":"M Mohty","year":"2010","unstructured":"Mohty M, Labopin M, Volin L, Gratwohl A, Socie G, Esteve J et al. Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood 2010; 116: 4439\u20134443.","journal-title":"Blood"},{"key":"BFbmt2016194_CR31","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2015.179","volume":"50","author":"NC Gorin","year":"2015","unstructured":"Gorin NC, Giebel S, Labopin M, Savani BN, Mohty M, Nagler A . Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects. Bone Marrow Transplant 2015; 50: 1495\u20131502.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016194_CR32","unstructured":"Parachnicova EKL, Mendeleeva L, Akhmerzaeva Z, Bondarenko S et al Autologous hematopoietic stem cell transplantation followed by prolonged maintenance provides survival benefit over only-chemotherapy in T-cell acute lymphoblastic leukemia: results of the RALL study group. 40th Annual Meeting of the EBMT, Milan, Italy 2014."},{"key":"BFbmt2016194_CR33","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","volume":"27","author":"MR Mansour","year":"2009","unstructured":"Mansour MR, Sulis ML, Duke V, Foroni L, Jenkinson S, Koo K et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol. J Clin Oncol 2009; 27: 4352\u20134356.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016194_CR34","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","volume":"113","author":"V Asnafi","year":"2009","unstructured":"Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K et al. NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood 2009; 113: 3918\u20133924.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016194","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:05:36Z","timestamp":1648062336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFbmt2016194"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.194","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]},"assertion":[{"value":"2 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}